[HTML][HTML] Oleoylethanolamide protects against acute liver injury by regulating Nrf-2/HO-1 and NLRP3 pathways in mice
J Hu, Z Zhu, H Ying, J Yao, H Ma, L Li… - Frontiers in …, 2021 - frontiersin.org
Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice
J Hu, Z Zhu, H Ying, J Yao, H Ma… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
[HTML][HTML] Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice
J Hu, Z Zhu, H Ying, J Yao, H Ma, L Li… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice.
J Hu, Z Zhu, H Ying, J Yao, H Ma, L Li… - Frontiers in …, 2020 - europepmc.org
Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …
mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple …